The Covid-19 vaccine remains on the CDC's revised schedule of childhood vaccinations despite HHS Secretary Robert F. Kennedy Jr.'s announcement.

The FDA also approved treprostinil (Yutrepia) inhalation powder for patients with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, said Liquidia.